Skip to main content

Table 4 Patient categories at baseline, 6 months and 12 months, and change of categories at 6 months and 12 months

From: Schizophrenia symptoms and functioning in patients receiving long-term treatment with olanzapine long-acting injection formulation: a pooled analysis

  

Categories at 6 (±1) months

   

Baseline category

Num. of patients1

A

B

C

D

E

Missing at 6 months2

Category improved2

Category worsened2

A

162 (14%)

86

26

7

0

0

43 (27%)

N.A.

33 (20%)

B

434 (37%)

61

210

9

12

1

141 (33%)

61 (14%)

13 (3%)

C

208 (18%)

68

16

61

8

1

54 (26%)

68 (33%)

9 (4%)

D

303 (26%)

14

80

18

62

2

127 (42%)

112 (37%)

N.A.

E

72 (6%)

3

14

3

18

7

27 (38%)

20 (28%)

N.A.

Missing

3 (0.3%)

0

0

0

0

0

3

  

Total

1182 (100%)

232 (20%)

346 (29%)

98 (8%)

100 (8%)

11 (1%)

395 (33%)

261 (26%)

55 (7%)

  

Categories at 12 (±3) months

   

Baseline category

Num. of patients 1

A

B

C

D

E

Missing at 1 year 2

Category improved 2

Category worsened 2

A

162 (14%)

83

22

7

1

0

49 (30%)

N.A.

30 (19%)

B

434 (37%)

58

169

7

11

4

185 (43%)

58 (13%)

15 (3%)

C

208 (18%)

62

21

36

3

0

86 (41%)

62 (30%)

3 (1%)

D

303 (26%)

20

60

16

43

1

163 (54%)

96 (32%)

N.A.

E

72 (6%)

7

12

4

8

4

37 (51%)

23 (32%)

N.A.

Missing

3 (0.3%)

0

0

0

0

0

3

  

Total

1182 (100%)

230 (19%)

284 (24%)

70 (6%)

66 (6%)

9 (1%)

523 (44%)

239 (24%)

48 (6%)

  1. Patients improving from baseline to 6 months/1 year are indicated in bold. Patients worsening from baseline to 6 months/1 year are indicated in bold italics. 1% to the column total across baseline categories; 2% to the row total within baseline category N.A.: not applicable.